Literature DB >> 19570854

Inhibition of macrophage activation by the myxoma virus M141 protein (vCD200).

Leiliang Zhang1, Marianne Stanford, Jia Liu, Catherine Barrett, Lei Jiang, A Neil Barclay, Grant McFadden.   

Abstract

The M141 protein of myxoma virus (MYXV) is a viral CD200 homolog (also called vOX-2) that inhibits macrophage activation in infected rabbits. Here, we show that murine myeloid RAW 264.7 cells became activated when infected with MYXV in which the M141 gene was deleted (vMyx-M141KO) but not with the parental wild-type MYXV. Moreover, transcript and protein levels of tumor necrosis factor and granulocyte colony-stimulating factor were rapidly upregulated in an NF-kappaB-dependent fashion in the RAW 264.7 cells infected with vMyx-M141KO. M141 protein is present in the virion and counteracts this NF-kappaB activation pathway upon infection with the wild-type MYXV. Our data suggest that upregulation of these classic macrophage-related proinflammatory cytokine markers following infection of myeloid cells with the M141-knockout MYXV is mediated via the rapid activation of the cellular NF-kappaB pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19570854      PMCID: PMC2738222          DOI: 10.1128/JVI.01078-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Immunomodulatory proteins of myxoma virus.

Authors:  J W Barrett; J X Cao; S Hota-Mitchell; G McFadden
Journal:  Semin Immunol       Date:  2001-02       Impact factor: 11.130

Review 2.  Immune responses to intracellular bacteria.

Authors:  B Raupach; S H Kaufmann
Journal:  Curr Opin Immunol       Date:  2001-08       Impact factor: 7.486

Review 3.  Interplay between poxviruses and the cellular ubiquitin/ubiquitin-like pathways.

Authors:  Leiliang Zhang; Nancy Y Villa; Grant McFadden
Journal:  FEBS Lett       Date:  2009-01-25       Impact factor: 4.124

4.  The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation.

Authors:  Alexander Hoffmann; Andre Levchenko; Martin L Scott; David Baltimore
Journal:  Science       Date:  2002-11-08       Impact factor: 47.728

5.  Induction of colony-stimulating factor expression following Staphylococcus or Salmonella interaction with mouse or human osteoblasts.

Authors:  K L Bost; J L Bento; J K Ellington; I Marriott; M C Hudson
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

6.  Kaposi's sarcoma-associated herpesvirus OX2 glycoprotein activates myeloid-lineage cells to induce inflammatory cytokine production.

Authors:  Young-Hwa Chung; Robert E Means; Joong-Kook Choi; Bok-Soo Lee; Jae U Jung
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  Measurement of nitric oxide in murine Hepatoma Hepa1c1c7 cells by reversed phase HPLC with fluorescence detection.

Authors:  Negar Gharavi; Ayman O S El-Kadi
Journal:  J Pharm Pharm Sci       Date:  2003 May-Aug       Impact factor: 2.327

8.  Characterization of the CD200 receptor family in mice and humans and their interactions with CD200.

Authors:  Gavin J Wright; Holly Cherwinski; Mildred Foster-Cuevas; Gary Brooke; Michael J Puklavec; Mike Bigler; Yaoli Song; Maria Jenmalm; Dan Gorman; Terri McClanahan; Man-Ru Liu; Marion H Brown; Jonathon D Sedgwick; Joseph H Phillips; A Neil Barclay
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

9.  Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis.

Authors:  Katerina Akassoglou; Ryan A Adams; Jan Bauer; Peter Mercado; Vivian Tseveleki; Hans Lassmann; Lesley Probert; Sidney Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

10.  The myxoma poxvirus protein, M11L, prevents apoptosis by direct interaction with the mitochondrial permeability transition pore.

Authors:  Helen Everett; Michele Barry; Xuejun Sun; Siow Fong Lee; Christine Frantz; Luc G Berthiaume; Grant McFadden; R Chris Bleackley
Journal:  J Exp Med       Date:  2002-11-04       Impact factor: 14.307

View more
  19 in total

1.  Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.

Authors:  Robin Mihrshahi; Marion H Brown
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

2.  Herpesvirus orthologues of CD200 bind host CD200R but not related activating receptors.

Authors:  Lai Shan Kwong; Munir Akkaya; A Neil Barclay; Deborah Hatherley
Journal:  J Gen Virol       Date:  2015-11-04       Impact factor: 3.891

3.  Cytomegalovirus e127 protein interacts with the inhibitory CD200 receptor.

Authors:  Mildred Foster-Cuevas; Tina Westerholt; Mohamed Ahmed; Marion H Brown; A Neil Barclay; Sebastian Voigt
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

4.  Membrane-associated and secreted forms of the Rhesus macaque rhadinovirus-encoded CD200 homologue and cellular CD200 demonstrate differential effects on Rhesus Macaque CD200 Receptor signaling and regulation of myeloid cell activation.

Authors:  Ryan D Estep; Aparna N Govindan; Kristin Fitzpatrick; Tiffany C Blair; S A Rahim Rezaee; David J Blackbourn; Scott W Wong
Journal:  J Virol       Date:  2020-12-16       Impact factor: 5.103

Review 5.  The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics.

Authors:  Jia Liu; Sonia Wennier; Grant McFadden
Journal:  Microbes Infect       Date:  2010-09-09       Impact factor: 2.700

6.  Cellular distribution of CD200 receptor in rats and its interaction with cytomegalovirus e127 protein.

Authors:  Mohamed A El-Mokhtar; Agnieszka Bauer; Julia Madela; Sebastian Voigt
Journal:  Med Microbiol Immunol       Date:  2018-07-21       Impact factor: 3.402

7.  Heterogeneity in the CD200R paired receptor family.

Authors:  Munir Akkaya; A Neil Barclay
Journal:  Immunogenetics       Date:  2009-12-05       Impact factor: 2.846

8.  The rhesus rhadinovirus CD200 homologue affects immune responses and viral loads during in vivo infection.

Authors:  Ryan D Estep; Stephanie D Rawlings; Helen Li; Minsha Manoharan; Elizabeth T Blaine; Megan A O'Connor; Ilhem Messaoudi; Michael K Axthelm; Scott W Wong
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

9.  CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia.

Authors:  S J Coles; E C Y Wang; S Man; R K Hills; A K Burnett; A Tonks; R L Darley
Journal:  Leukemia       Date:  2011-01-28       Impact factor: 11.528

10.  Structures of CD200/CD200 receptor family and implications for topology, regulation, and evolution.

Authors:  Deborah Hatherley; Susan M Lea; Steven Johnson; A Neil Barclay
Journal:  Structure       Date:  2013-04-18       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.